APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain Management Drugs

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

Selected research

Market Outlook & Growth Opportunities

Global Pain Management Drugs Market Outlook and Growth Opportunities 2026

21 December 2025191 pages

Choose your research edition.

Industry ResearchPain Management Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain Management Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pain Management Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain Management Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain Management Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

Read the full market overview

This report provides an overview of the global Pain Management Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pain Management Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pain Management Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pain Management Drugs market.

Pain Management Drugs Segment by Company

GSK

Pfizer

Grunenthal

Sanofi

Bayer

AstraZeneca

Eli Lilly

Endo

Merck

Yunnan Baiyao

Teikoku Seiyaku

Teva

J&J

Assertio Therapeutics

Allergan

Pain Management Drugs Segment by Type

Generic Opioids

Branded Opioids

NSAIDs

Others

Pain Management Drugs Segment by Application

Hospitals

Drugstores

Others

Pain Management Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pain Management Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pain Management Drugs key companies, revenue, market share, and recent developments.

3. To split the Pain Management Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pain Management Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pain Management Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Pain Management Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pain Management Drugs industry.

Chapter 3: Detailed analysis of Pain Management Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pain Management Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pain Management Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pain Management Drugs Industry Trends Table 2. Pain Management Drugs Industry Drivers Table 3. Pain Management Drugs Industry Opportunities and Challenges Table 4. Pain Management Drugs Industry Restraints Table 5. Global Pain Management Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pain Management Drugs Revenue Share by Company (2021-2026) Table 7. Global Pain Management Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pain Management Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Pain Management Drugs Company, Product Type & Application Table 10. Global Pain Management Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pain Management Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Generic Opioids Table 15. Significant Companies of Branded Opioids Table 16. Significant Companies of NSAIDs Table 17. Significant Companies of Others Table 18. Global Pain Management Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pain Management Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pain Management Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pain Management Drugs Sales Value Share by Type (2021-2026) Table 22. Global Pain Management Drugs Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Drugstores Table 25. Significant Companies of Others Table 26. Global Pain Management Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pain Management Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pain Management Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pain Management Drugs Sales Value Share by Application (2021-2026) Table 30. Global Pain Management Drugs Sales Value Share by Application (2027-2032) Table 31. Global Pain Management Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pain Management Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pain Management Drugs Sales Value Share by Region (2021-2026) Table 34. Global Pain Management Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pain Management Drugs Sales Value Share by Region (2027-2032) Table 36. Global Pain Management Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pain Management Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pain Management Drugs Sales Value Market Share by Country (2021-2026) Table 39. Global Pain Management Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pain Management Drugs Sales Value Market Share by Country (2027-2032) Table 41. GSK Company Information Table 42. GSK Business Overview Table 43. GSK Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. GSK Pain Management Drugs Product Portfolio Table 45. GSK Recent Development Table 46. Pfizer Company Information Table 47. Pfizer Business Overview Table 48. Pfizer Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Pfizer Pain Management Drugs Product Portfolio Table 50. Pfizer Recent Development Table 51. Grunenthal Company Information Table 52. Grunenthal Business Overview Table 53. Grunenthal Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Grunenthal Pain Management Drugs Product Portfolio Table 55. Grunenthal Recent Development Table 56. Sanofi Company Information Table 57. Sanofi Business Overview Table 58. Sanofi Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Sanofi Pain Management Drugs Product Portfolio Table 60. Sanofi Recent Development Table 61. Bayer Company Information Table 62. Bayer Business Overview Table 63. Bayer Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Bayer Pain Management Drugs Product Portfolio Table 65. Bayer Recent Development Table 66. AstraZeneca Company Information Table 67. AstraZeneca Business Overview Table 68. AstraZeneca Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. AstraZeneca Pain Management Drugs Product Portfolio Table 70. AstraZeneca Recent Development Table 71. Eli Lilly Company Information Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Eli Lilly Pain Management Drugs Product Portfolio Table 75. Eli Lilly Recent Development Table 76. Endo Company Information Table 77. Endo Business Overview Table 78. Endo Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Endo Pain Management Drugs Product Portfolio Table 80. Endo Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Merck Pain Management Drugs Product Portfolio Table 85. Merck Recent Development Table 86. Yunnan Baiyao Company Information Table 87. Yunnan Baiyao Business Overview Table 88. Yunnan Baiyao Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Yunnan Baiyao Pain Management Drugs Product Portfolio Table 90. Yunnan Baiyao Recent Development Table 91. Teikoku Seiyaku Company Information Table 92. Teikoku Seiyaku Business Overview Table 93. Teikoku Seiyaku Pain Management Drugs Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 94. Teikoku Seiyaku Pain Management Drugs Product Portfolio Table 95. Teikoku Seiyaku Recent Development Table 96. Teva Company Information Table 97. Teva Business Overview Table 98. Teva Pain Management Drugs Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 99. Teva Pain Management Drugs Product Portfolio Table 100. Teva Recent Development Table 101. J&J Company Information Table 102. J&J Business Overview Table 103. J&J Pain Management Drugs Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 104. J&J Pain Management Drugs Product Portfolio Table 105. J&J Recent Development Table 106. Assertio Therapeutics Company Information Table 107. Assertio Therapeutics Business Overview Table 108. Assertio Therapeutics Pain Management Drugs Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 109. Assertio Therapeutics Pain Management Drugs Product Portfolio Table 110. Assertio Therapeutics Recent Development Table 111. Allergan Company Information Table 112. Allergan Business Overview Table 113. Allergan Pain Management Drugs Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 114. Allergan Pain Management Drugs Product Portfolio Table 115. Allergan Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Pain Management Drugs Product Image Figure 2. Global Pain Management Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain Management Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Pain Management Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Generic Opioids Image Figure 8. Branded Opioids Image Figure 9. NSAIDs Image Figure 10. Others Image Figure 11. Global Pain Management Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pain Management Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pain Management Drugs Sales Value Share by Type (2021-2032) Figure 14. Hospitals Image Figure 15. Drugstores Image Figure 16. Others Image Figure 17. Global Pain Management Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pain Management Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pain Management Drugs Sales Value Share by Application (2021-2032) Figure 20. Global Pain Management Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pain Management Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Opioids
  • Branded Opioids
  • NSAIDs
  • Others
Applications
  • Hospitals
  • Drugstores
  • Others
Companies covered
  • GSK
  • Pfizer
  • Grunenthal
  • Sanofi
  • Bayer
  • AstraZeneca
  • Eli Lilly
  • Endo
  • Merck
  • Yunnan Baiyao
  • Teikoku Seiyaku
  • Teva
  • J&J
  • Assertio Therapeutics
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pain Management Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pain Management Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pain Management Drugs Market Dynamics
  1. 2.1 Pain Management Drugs Industry Trends
  2. 2.2 Pain Management Drugs Industry Drivers
  3. 2.3 Pain Management Drugs Industry Opportunities and Challenges
  4. 2.4 Pain Management Drugs Industry Restraints
3 Pain Management Drugs Market by Company
  1. 3.1 Global Pain Management Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Pain Management Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Pain Management Drugs Company Ranking (2024-2026)
  4. 3.4 Global Pain Management Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Pain Management Drugs Company Product Type and Application
  6. 3.6 Global Pain Management Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pain Management Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pain Management Drugs Market by Type
  1. 4.1 Pain Management Drugs Type Introduction
  2. 4.1.1 Generic Opioids
  3. 4.1.2 Branded Opioids
  4. 4.1.3 NSAIDs
  5. 4.1.4 Others
  6. 4.2 Global Pain Management Drugs Sales Value by Type
  7. 4.2.1 Global Pain Management Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pain Management Drugs Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pain Management Drugs Sales Value Share by Type (2021-2032)
5 Pain Management Drugs Market by Application
  1. 5.1 Pain Management Drugs Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Drugstores
  4. 5.1.3 Others
  5. 5.2 Global Pain Management Drugs Sales Value by Application
  6. 5.2.1 Global Pain Management Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pain Management Drugs Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pain Management Drugs Sales Value Share by Application (2021-2032)
6 Pain Management Drugs Regional Value Analysis
  1. 6.1 Global Pain Management Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pain Management Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pain Management Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pain Management Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pain Management Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pain Management Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pain Management Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pain Management Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pain Management Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
7 Pain Management Drugs Country-level Value Analysis
  1. 7.1 Global Pain Management Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pain Management Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pain Management Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pain Management Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pain Management Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pain Management Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pain Management Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pain Management Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pain Management Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pain Management Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pain Management Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pain Management Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pain Management Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pain Management Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pain Management Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pain Management Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pain Management Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pain Management Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pain Management Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pain Management Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pain Management Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pain Management Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pain Management Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pain Management Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pain Management Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pain Management Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pain Management Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pain Management Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pain Management Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pain Management Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pain Management Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pain Management Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Pain Management Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Pain Management Drugs Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Pain Management Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Pain Management Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Grunenthal
  14. 8.3.1 Grunenthal Company Information
  15. 8.3.2 Grunenthal Business Overview
  16. 8.3.3 Grunenthal Pain Management Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grunenthal Pain Management Drugs Product Portfolio
  18. 8.3.5 Grunenthal Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Pain Management Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Pain Management Drugs Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Pain Management Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Pain Management Drugs Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Pain Management Drugs Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Pain Management Drugs Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 Eli Lilly
  38. 8.7.1 Eli Lilly Company Information
  39. 8.7.2 Eli Lilly Business Overview
  40. 8.7.3 Eli Lilly Pain Management Drugs Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly Pain Management Drugs Product Portfolio
  42. 8.7.5 Eli Lilly Recent Developments
  43. 8.8 Endo
  44. 8.8.1 Endo Company Information
  45. 8.8.2 Endo Business Overview
  46. 8.8.3 Endo Pain Management Drugs Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Endo Pain Management Drugs Product Portfolio
  48. 8.8.5 Endo Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Pain Management Drugs Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Pain Management Drugs Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Yunnan Baiyao
  56. 8.10.1 Yunnan Baiyao Company Information
  57. 8.10.2 Yunnan Baiyao Business Overview
  58. 8.10.3 Yunnan Baiyao Pain Management Drugs Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yunnan Baiyao Pain Management Drugs Product Portfolio
  60. 8.10.5 Yunnan Baiyao Recent Developments
  61. 8.11 Teikoku Seiyaku
  62. 8.11.1 Teikoku Seiyaku Company Information
  63. 8.11.2 Teikoku Seiyaku Business Overview
  64. 8.11.3 Teikoku Seiyaku Pain Management Drugs Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Teikoku Seiyaku Pain Management Drugs Product Portfolio
  66. 8.11.5 Teikoku Seiyaku Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Pain Management Drugs Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Pain Management Drugs Product Portfolio
  72. 8.12.5 Teva Recent Developments
  73. 8.13 J&J
  74. 8.13.1 J&J Company Information
  75. 8.13.2 J&J Business Overview
  76. 8.13.3 J&J Pain Management Drugs Revenue and Gross Margin (2021-2026)
  77. 8.13.4 J&J Pain Management Drugs Product Portfolio
  78. 8.13.5 J&J Recent Developments
  79. 8.14 Assertio Therapeutics
  80. 8.14.1 Assertio Therapeutics Company Information
  81. 8.14.2 Assertio Therapeutics Business Overview
  82. 8.14.3 Assertio Therapeutics Pain Management Drugs Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Assertio Therapeutics Pain Management Drugs Product Portfolio
  84. 8.14.5 Assertio Therapeutics Recent Developments
  85. 8.15 Allergan
  86. 8.15.1 Allergan Company Information
  87. 8.15.2 Allergan Business Overview
  88. 8.15.3 Allergan Pain Management Drugs Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Allergan Pain Management Drugs Product Portfolio
  90. 8.15.5 Allergan Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst